GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sunny Pharmtech 6676.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

8.03

+15.04%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2024

Revenue

TWD 418.0m

FY2018FY2024

Net income

−TWD 156.0m

FY2018FY2024

Free cash flow

−TWD 86.6m

FY2018FY2024

Shareholders' equity

TWD 1.05bn

FY2018FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
RevenueTWD 418.0mTWD 428.8mTWD 359.6mTWD 241.0mTWD 419.9mTWD 234.5mTWD 142.8m
Research and developmentTWD 219.3mTWD 208.9mTWD 255.9mTWD 171.4mTWD 182.0mTWD 205.6mTWD 305.4m
Operating income−TWD 163.0m−TWD 72.1m−TWD 187.6m−TWD 176.0m−TWD 74.3m−TWD 214.0m−TWD 299.0m
Net income−TWD 156.0m−TWD 63.3m−TWD 170.2m−TWD 174.8m−TWD 101.8m−TWD 226.3m−TWD 299.6m
Diluted earnings per share-1.05-0.43-1.23-1.28-0.77-1.76-2.11

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assetsTWD 1.59bnTWD 1.71bnTWD 1.63bnTWD 1.59bnTWD 1.50bnTWD 1.62bnTWD 1.43bn
Cash and short-term investmentsTWD 141.1mTWD 277.7mTWD 289.7mTWD 285.0mTWD 244.1mTWD 336.7mTWD 161.7m
Total liabilitiesTWD 540.7mTWD 512.4mTWD 660.3mTWD 468.3mTWD 455.2mTWD 471.8mTWD 411.9m
DebtTWD 386.3mTWD 391.4mTWD 562.7mTWD 366.3mTWD 384.6mTWD 390.2mTWD 319.7m
Shareholders' equityTWD 1.05bnTWD 1.20bnTWD 969.3mTWD 1.13bnTWD 1.04bnTWD 1.15bnTWD 1.02bn
Shares outstanding149m147m139m136m131m129m142m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations−TWD 37.1mTWD 38.1mTWD 26.9m−TWD 34.4m−TWD 26.0m−TWD 117.9m−TWD 305.5m
Capital spending−TWD 49.5m−TWD 145.2m−TWD 195.3m−TWD 160.5m−TWD 68.8m−TWD 78.9m−TWD 265.6m
Free cash flow−TWD 86.6m−TWD 107.1m−TWD 168.4m−TWD 194.9m−TWD 94.9m−TWD 196.7m−TWD 571.2m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
RevenueTWD 105.7mTWD 184.5mTWD 233.6mTWD 251.5mTWD 177.4mTWD 204.2mTWD 155.4mTWD 120.5m
Operating income−TWD 139.1m−TWD 114.9mTWD 48.1m−TWD 19.4m−TWD 52.7m−TWD 70.3m−TWD 95.4m−TWD 84.6m
Net income−TWD 152.8m−TWD 116.7m−TWD 39.3m−TWD 11.2m−TWD 52.1m−TWD 63.9m−TWD 106.4m−TWD 87.4m
Diluted earnings per share-1.03-0.78-0.26-0.08-0.35-0.46-0.77-0.64
Cash from operations−TWD 96.0m−TWD 14.0m−TWD 22.0mTWD 15.0mTWD 26.0mTWD 37.0m—−TWD 17.0m
Capital spending−TWD 9.0m−TWD 23.0m−TWD 22.0m−TWD 77.0m−TWD 66.0m−TWD 48.0m—−TWD 80.0m
Free cash flow−TWD 105.0m−TWD 37.0m−TWD 44.0m−TWD 62.0m−TWD 40.0m−TWD 11.0m—−TWD 97.0m
Total assetsTWD 1.49bnTWD 1.59bnTWD 1.67bnTWD 1.71bnTWD 1.64bnTWD 1.63bn—TWD 1.59bn
Cash and short-term investmentsTWD 81.5mTWD 141.1mTWD 221.2mTWD 277.7mTWD 272.0mTWD 289.7m—TWD 285.0m
DebtTWD 395.5mTWD 342.0mTWD 349.4mTWD 15.1mTWD 215.3mTWD 202.6m—TWD 72.9m
Shareholders' equityTWD 894.9mTWD 1.05bnTWD 1.16bnTWD 1.20bnTWD 926.4mTWD 969.3m—TWD 1.13bn

Financial ratios

Data as of 28 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin—-35.2%-12.1%-46.1%-70.2%-22.6%-93.0%
Net margin—-37.3%-14.8%-47.3%-72.5%-24.2%-96.5%
Return on equity—-14.9%-5.3%-17.6%-15.5%-9.7%-19.7%
Return on assets—-9.8%-3.7%-10.4%-11.0%-6.8%-14.0%
Free cash flow yield—0.9%12.9%16.6%9.5%3.4%-3.1%
Revenue growth—-2.5%19.3%49.2%-42.6%79.1%—
Earnings growth—146.4%-62.8%-2.6%71.8%-55.0%—
Current ratio—2.21x4.12x1.48x2.85x3.10x3.93x
Debt to equity—0.33x0.29x0.55x0.30x0.08x0.05x
Equity ratio—65.9%70.1%59.5%70.6%69.6%70.8%
Interest coverage—-16.20x-4.63x-36.12x-30.08x-13.98x-26.33x
R&D as a share of sales—52.5%48.7%71.2%71.1%43.3%87.7%
Buybacks as a share of market value-0.0%-1.2%-6.1%-1.5%-3.8%-2.2%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue20.2%12.3%—
Operating income-2.5%-5.3%—
Net income-3.7%-7.2%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-27.8%-41.4%-42.2%—
Net margin-25.9%-39.0%-42.5%—

Valuation history

At each fiscal year end

FY2024FY2023FY2022
Price to earnings-20.9-79.6-16.0
Price to sales7.811.87.6

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.